Clinical Trial Update: Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of denileukin diftitox for non-Hodgkin lymphoma. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Denileukin diftitox (denileukin diftitox)

Snippet

Sponsor: Pharmatech Oncology | Conditions: Leukemia, Lymphoma | Phase 2 | Status: UNKNOWN